Abnormal T-cell function in B-cell chronic lymphocytic leukaemia

Leukemia and Lymphoma

Volumn 44, Issue 3, 2003, Pages 383-389

  Scrivener, S ^a   Goddard, R V ^a   Kaminski, E R ^a   Prentice, A G ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

B CLL; Cytokine; Secretion; T cell function

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR CCR4; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; LEUKEMIA ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE SURFACE MARKER; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; B CELL LEUKEMIA; B LYMPHOCYTE; BONE MARROW; CELL MEDIATED CYTOTOXICITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CLONAL VARIATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOCYTOSIS; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RESTRICTION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANTIBODY FORMATION; ANTIGENS, CD; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CELL ADHESION MOLECULES; COLONY-FORMING UNITS ASSAY; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE PROGRESSION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LEUKEMIA, B-CELL, CHRONIC; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COOPERATION; LYMPHOCYTE COUNT; MITOGENS; NEOPLASM PROTEINS; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 0037348740     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000029993     Document Type: Review

References (80)

1. Caligaris-Cappio, F. and Hamblin, T.J. (1999) "B-cell chronic lymphocytic leukaemia: a bird of a different feather", Journal of Clinical Oncology 17(1), 399-408.
2. Bannerji, R. (2000) "Update on the biology of chronic lymphocytic leukaemia", Current Opinion in Immunology 12, 22-29.
3. Danescu, M., Rubio-Trujillo, M., Bron, D., Delespesse, G. and Sarfati (1992) "Interleukin 4 protects chronic lymphocytic leukaemia B-cells from death by apopyosis and upregulates bcl-2 expression", Journal of Experimental Medicine 176, 1319-1326.
4. Kay, N.E., Johnson, J.D., Stanek, R. and Douglas, S.D., (1979) "T-cell subpopulations in chronic lymphocytic leukaemia: Abnormalities in distribution and in in vitro receptor maturation", Blood 54(2), 540-543.
5. Callery, R.T., Strekkauskas, A.J., Yanovich, S., Marks, S., Rosenthal, D. and Schlossman, S.F. (1980) "Functional abnormalities associated with T lymphocytes from patients with chronic lymphocytic leukaemia", Clinical Immunology and Immunopathology 17, 451-458.
6. Matutes, E., Wechsler, A., Gomez, R., Cherchi, M. and Catovsky, D. (1981) "Unusual T-cell phenotype in advanced B-chronic lymphocytic leukaemia", British Journal of Haematology 49, 635-642.
7. Herrman, F., Lochner, A., Phlippen, H., Jauer, B. and Rubl, H. (1982) "Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type", Clinical Experimental Immunology 49, 157-162.
8. Clark, E.A. and Ledbetter, J.A. (1984) "How B and T cells talk to each other", Nature 367, 425-428.
9. Robey, L. and Allison, J.P. (1995) "T-cell activation: integration of signals from the antigen receptor and costimulatory molecules", Immunology Today 16(7), 306-310.
10. Bell, D., J.W. and Banchereau, J. (1999) "Dendritic cells", Advances in Immunology 72, 255.
11. Catovsky, D., Miliani, E., Okos, A. and Galton, D.A.G. (1974) "Clinical significance of T-cells in chronic lymphocytic leukaemia", The Lancet 28, 751-752.
12. Rezvany, M.R., Jeddi-Tehrani, M., Osterborg, A., Kimby, E., Wigzell, H. and Mellstadt, H. (1999) "Oligoclonal TCR BV gene usage in B-cell chronic lymphocytic leukaemia: major perturbations are preferentially seen within the CD4 T cell subset", Blood 94, 1063-1069.
13. Rezvany, M.R., Jeddi-Tehrani, M., Rabbani, H., Lewin, N., Avila-Carino, J., Osterborg, A., Wigzell, H. and Mellstedt, H. (2000) "Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia", British Journal of Haematology 111, 608-617.
14. Scrivener, S., Kaminski, E.R., Demaine, A. and Prentice, A.G. (2001) "Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation", British Journal of Haematology 112, 959-964.
15. Ghia, P., Strola, G., Granziero, L., Ruffing, N., Chilosi, M. and Caligaris-Cappio, F. (2001) "Chronic lymphocytic leukaemia B cells are endowed with the capacity to attract T cells upon CD40 stimulation", Leukaemia and Lymphoma 42, 51-77.
16. Goddard, R.V., Prentice, A.G., Copplestone, J.A. and Kaminski, E.R. (2001) "Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxica T-cell responses using autologous dendritic cells pulsed with tumour lysate", Clinical and Experimental Immunology 126, 16-28.
17. Briggs, P.G., Kraft, N. and Atkins, R.C. (1989) "T cells and CD45R expression in B-chronic lymphocytic leukaemia", Leukaemia Research 14(2), 155-159.
18. Kimby, E., Mellstedt, H., Nillson, B., Bjorkholm, M. and Holm G. (1989) "Differences in blood T and NK cell populations between chronic lymphocytic leukaemia of B-cell type (B-CLL) and monoclonal B-lymphocytosis of undetermined significance (B-MLUS)", Leukaemia 3(7), 501-504.
19. Semenzato, G., Pezzutto, A., Foa, R., Laura, F. and Raimondo, R. (1983) "T lymphocytes in B-cell chronic lymphocytic leukaemia: characterisation by monoclonal antibodies and correlation with Fc receptors", Clinical Immnunology and Immunopathology 26, 155-161.
20. Totterman, T.H., Carlsson, M., Simonsson, B., Bengtsson, M. and Nilsson, K. (1989) "T-cell activation and subset patterns are altered in B-CLL and correlate with stage of the disease", Blood 74(2), 786-792.
21. Dianzani, U., Omede, P., Marmont, F., Di Franco, D., Fusaro, A., Bragardo, M. Redoglia, V., Giaretta, F., Marione, L. and Boccadoro, M. (1994) "Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukaemia: correlation with disease status and neoplastic phenotype", Blood 83(8), 2198-2205.
22. Huang, L. and Crispe, N. (1992) "Distinctive selection mechanisms govern the T cell receptor repertoire of peripheral CD4″CD8″ α/β T cells", Journal of Experimental Medicine 176, 699-706.
23. Von Boehmer, H. (1992) "Thymic selection: a matter of life and death", Immunology Today 13, 454-458.
24. Foa, R., Catovsky, D., Lauria, F., Zafar, M.N. and Galston, D.A.G. (1981) "T lymphocytes in B-cell chronic lymphocytic leukaemia", Haematologica 66(1), 104-116.
25. Foa, R., Lauria, F., Catovsky, D. and Glaton, D.A.G. (1982) "Reduced T-colony forming capacity in B-chronic lymphocytic leukaemia-II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia", Leukaemia Research 6(3), 329-333.
26. Zaknoen, S.L. and Kay, N.E. (1990) "Immunoregulatory cell dysfunction in chronic B-cell leukaemias", Blood Reviews 4, 165-174.
27. Prieto, A., Garcia-Suarez, J., Reyes, E., Lapena, P., Hernandez, M. and Alvarez-Mon, M. (1993) "Diminished DNA synthesis in T cells from B chronic lymphocytic leukaemia after phytohaermagglutinin, anti-CD3 and phorbal myristate acetate mitogenic signals", Experimental Hematology 21(12), 1563-1569.
28. Scrivener, S., Prentice, A.G., Kaminski, E.R. and Demaine, A. (2001b) "Activation and interaction markers and cytokine production are dysfunctional in T-cells from B-cell chronic lymphocytic leukaemia patients", Leukaemia and Lymphoma 42, S1:36.
29. Utsinger, P.D. (1975) "Impaired T-cell transformation in chronic lymphocytic leukaemia (CLL): demonstration of a blastogenesis inhibitory factor M", Blood 46(6), 883-890.
30. Hersey, P., Wotherspoon, J., Reid, G. and Gunz, F.W. (1979) "Hypogammaglobulinaemia associated with abnormalities of both B and T lymphocytes in patients with chronic lymphocytic leukaemia", Clinical and Experimental Immunology 39, 698-707.
31. Lauria, F., Foa, R., Mantovani, V., Fierro, M.T., Catovsky, D. and Tura, S. (1983) "T-cell functional abnormality in B-chronic lymphocytic leukaemia: evidence of a defect of the T-helper subset", British Journal of Haematology 54, 277-283.
32. Sieber, G., Enders, B., Herrman, F. and Ruhl, H. (1981) "B and T cell function in patients with chronic lymphocytic leukaemia", Immunobiology 160, 111-112.
33. Antica M., Kusic, B., Spaventi, R., Jaksic, B. and Vitale, B. (1993) "Functional differences of T cells in B-chronic lymphocytic leukaemia", Leukaemia and lymphoma 9, 133-140.
34. + tumour cells in B chronic lymphocytic leukaemia", Blood 91(11), 4273-4281.
35. Makgoba, M.W., Sanders, M.E. and Shaw, S. (1989) "The CD2- LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition", Immunology Today 10(12), 417-422.
36. Figdor, C.G., van Kooyk, Y. and Keizer, G.D. (1990) "On the mode of action of LFA-1", Immunology Today 11(8), 277-280.
37. Parham, P. (2000) In: The Immune System Current Trends (Garland Publishing/Elsevier Science, London).
38. Wen, T., Mellstedt, H. and Jondal, M. (1990) "Presence fo clonal T cell populations in chronic B lymphocytic leukaemia and smoldering myeloma", Journal of Experimental Medicine 171, 659-666.
39. Serrano, D., Monteiro, J., Allen, S.L., Kolitz, J., Schulman, P., Lichtman, S.M., Buchbinder, A., Vinciguerra, V.P., Chiorazzi, N. and Gregersen, P.K. (1997) "Clonal expression within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukaemia", Journal of Immunology 158, 1482-1489.
40. Frolova, E.A., Richards, S.J., Jones, R.A., Rawstron, A., Masters, P.S., Teasdale, J., Short, M., Jack, A.S. and Scott, C.S. (1995) "Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL)", Leukaemia and Lymphoma 16(3-4), 307-318.
41. Rassenti, L.Z., Wierda, W.G. and Kipps, T.J. (2001a) "Proliferation of CLL T cells in response to autologous CD154-modified B cells results in expansion of the aberrant TCR repertoire", Leukaemia and Lymphoma 42, S1:32.
42. Rassenti, L.Z., Widkopf, G.F., Rai, K.R., Catovsky, D. and Kipps, T.J. (2001b) "Chronic lymphocytic leukaemia is associated with acquired changes in the T-cell receptor repertoire", Leukaemia and Lymphoma 42, S:32.
43. Frydecka, I., Kaczmarek, P., Bocko, D., Kosmaczewska, A. and Ciszak, L. (1998) "Alterations in signal transducing molecule (CD3 in patients with neoplastic diseases", Archivum Immunologiae et Therapie Experimentalis 46, 355-359.
44. Lenschow, D.J., Walunas, T.L. and Bluestone, J.A. (1996) "CD28/B7 system of T cell costimulation", Annual Reviews in Immunology 14, 233-258.
45. Grewal, I.S. and Flavell, R.A. (1997) "The CD40-ligand at the centre of the immune universe?", Immunological Research 16, 59-70.
46. Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, J.M., Thompson, C.B. and Bluestone, J.A. (1994) "CTLA-4 can function as a negative regulator of T-cell activation", Immunity 1, 405-413.
47. Krummel, M.F. and Allison, J.P. (1995) "CD28 and CTLA-4 have opposing effects on the response of T-cells to stimulation", Journal of Experimental Medicine 182, 459-465.
48. Frydecka, I.F., Bocko, D.B., Kosmacaewska, A.K., Kuliczkowski, K.K., Woloviec, D.W., Ciszak, L.C., Teodorowska, R.T. and Kochanowska, I.K. (2001) "Expression of down-regulatory CTLA-4 molecule on peripheral blood T lymphocytes in patients with B-cell chronic lymphocytic leukaemia", The Haematology Journal 1(Suppl. 1), 38.
49. Tivol, E.A., Borriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A. and Sharpe, A.H. (1995) "Loss of CTLA-4 leads to massive lymphoproliferation and fatal multi-organ tissue destruction, revealing a critical negative regulatory role of CTLA-4", Immunity 3, 541-547.
50. Bai, X.-F., Lin, J., May, K.F., Guo, Y., Zheng, P. and Lin, Y.(2002) "B7-CTKLA4 interaction promoted cognate destruction of tumour cells to by cytotoxic T lymphocytes in vivo", Blood 99, 2880-2889.
51. Cantwell, M., Hua, T., Pappas, J. and Kipps, T. (1999) "Acquired CD40-ligand deficiency in chronic lymphocytic leukaemia", Nature Medicine 3, 984-989.
52. Brugnoni, D., Rossi, G., Tucci, A., Atteneo, R. and Airo, P. (1995) Study of CD40 ligand expression in B cell chronic lymphocytic leukaemia", Haematologica 80, 440-442.
53. Kay, N.E. and Kaplan, M.E. (1986) "Defective T cell responsiveness in chronic lymphocytic leukaemia: analysis of activatio events", Blood, 67 578-581.
54. Garcia-Suarez, J., Prieto, A., Reyes, E., Merino, J.L. and Alvarez-Mon, M. (1991) "Increased percentage of activated T Lymphocytes in B cell lymphocytic leukaemia (B-CLL) patients", British Journal of Haematology 69, 657-658.
55. Foa, R.; Giovarelli, M. and Jemma, C. et al. (1985) "Interleukin-2 (IL2) and interferon gamma production by T lymphocytes from patients with B-chronic lymphocytic leukaemia: evidence that normally released IL″ is absorbed by the neoplastic B cell population", Blood 66 614-619.
56. Rossi, J.F.; Klein, B.; Commes, T.; Jourdan, M. and Janbon, C. (1998) "Interleukin-2 production in bone marrow of normal individuals and patients associated with B-chronic lymphocytic leukaemia", British Journal of Haematology 68 207-212.
57. Zaki, M.H., Patten, N., Bachinsky, M., Nowell, P.C. and Morre, J.S. (2000) "TGFβ network alterations in B-CLL: overexpression of type II TGFβ receptor associated with G0/G1 cell cycle arrest in the non-neoplastic T cells", Blood 96(11), 750a, Suppl. 1.
58. De-Totero, D., Reato, G., Mauro, F., Cignetti, A., Ferrini, S., Guarini, A., Gobbi, M., Grossi, C.E. and Foa, R. (1999) "IL-4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemia", British Journal of Haematology 104(3), 489-599.
59. Epstein, L.B. and Cline, M.J. (1974) " Chronic lymphocytic leukaemia - studies on mitogen-stimulated lymphocyte interferon as a new technique for assessing T lymphocyte effector function", Clinical and Experimental Immunology 16, 553-563.
60. Hill, S.J., Peters, S.H., Ayliffe, M.J., Merceica, J. and Bansal, A.S. (1999) "Reduced IL-4 and interferon-gamma (IFN-γ) expression by CD4 T cells in patients with chronic lymphocytic leukaemia", Clinical and Experimental Immunology 117, 8-11.
61. Ayanlar-Batuman, O., Ebert, E. and Hauptman, S.P. (1986) "Defective interleukin-2 production of responsiveness by T cells in patients with chronic lymphocytic leukaemia of B cell variety", Blood 67, 279-284.
62. Mu, X., Kay, N.E., Gosland, M. and Jennings, C.D. (1977) "Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: evidence for increased levels of cytoplasmic IL-4 in resting and activated CD8 T cells", British Journal of Haematology 96, 733-735.
63. Mainou-Fowler, T., Miller, S., Procter, S.J. and Dickinson, A.M. (2001) "The levels of TNF alpha, IL-4 and IL-10 production by T cells in B-cell chronic lymphocytic leukaemia (B-CLL)", Leukaemia Research 25(2), 157-163.
64. Kay, N.E., Han, L., Bone, N. and Williams, G. (2001) "Interleukin-4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+T cells from B-CLL patients: impact on clonal B-cell apoptosis", British Journal of Haemaotlogy 112, 760-767.
65. Janssen, O., Nerl, C. and Kabelitz, D. (1989) "T cells in B-cell chronic lymphocytic leukaemia: quantitative assessment by cytotoxic and interleukin-2 producing lymphocyte precursors by limiting dilution analysis", Blood 73(6), 1622-1626.
66. Zaki, M., Douglas, R., Patten, V., Bachinsky, M., Lamb, R., Owell, P. and Moore, J. (2000) "Disruption of the IFN-γ cytokine network in chronic lymphocytic leukaemia contributes to the resistance of leukemic B cells in apoptosis", Leukaemia Research 24(7), 611-621.
67. Hulkonen, J., Vilpo, J., Vilpo, L. and Hurme, M. (1998) "Diminished production of interleukin-6 in chronic lymphocytic leukaemia B-CLL) cells from patients at advanced stages of disease", British Journal of Haematology 100(3), 478-483.
68. Fernandez, L.A., MacSween, J.M. and Langley, G.R. (1983) "Normal T cell colony numbers in untreated patients with chronic lymphocytic leukaemia (CLL)", British Journal of Haematology 57, 97-104.
69. Jehn, U., Gross, H.J., Wachhlz, K. and Pauls, R. (1990) "Exogenous interleukin-2 (IL-2) reconstitutes deficient in-vitro T-cell growth of patients with chronic lymphocytic leukaemia of B-cell lineage (B-CLL)", Anticancer Research 10(4), 929-934.
70. Burger, T., Molnar, L., Schmelczer, M., Tovari, E., Szabo, A., Opaal, M. and Kiralyfalvi, L. (1990) "Changes of T-lymphocytesubsets and their consequences in B-CLL", Folia Haematologica 117, 115-125.
71. Stark, P., Shohat, B., Kadosh, S. and Shaklai, M. (1999) "Impaired T-lymphocyte function in B-chronic lymphocytic leukaemia as measured by the local zenogenic graft versus host reaction", Clinical and Laboratory Haematology 21, 187-191.
72. Terstappen, L.W.M.M., DE Grooth, B.G., Segers-Nolten, I. and Greve, J. (1990) "Cytotoxic lymphocytes in B-cell chronic lymphocytic leukaemia", Blut 60, 81-87.
73. Sherman, W., Lin, Z., Inghirami, G., Reed, E.F., Harris, P.E. and Sucia-Foca, N.M. (1993) "Major histocompatibility complex-restricted recognition of autologous chronic lymphocytic leukaemia by tumour-specific T cells", Immunologic Research 12, 338-348.
74. Van den Hove, L.E., Van Gool, S.W., Vandengerghe, P., Bakkus, M., Thielmans, K., Boogaerts, M.A. and Ceuppens, J.L. (1997) "CD40 triggering of chronic lymphocytic leukaemia B-cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules", Leukaemia 11, 572-580.
75. Dazzi, F., D-andrea, E., Biasi, G., De Silvestro, G., Daidano, G., Schena, M., Tison, T., Vianello, F., Girolami, A. and Caligaris-C∼appio, F. (1995) "Failure of B cells of chronic lymphocytic leukaemia in presenting soluble and alloantigens", Clinical Immunology and Immunopathology 75, 26-32.
76. Buhmann, R., Nolte, A., Westhaus, D., Emmerich, B. and Hallek, M. (1999) "CD40-activated B-cell chronic lymphocytic leukaemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells", Blood 93, 1992-2002.
77. Farace, F., Orlanducci, F., Dietrich, P.Y., Gaudin, C., Angevin, E., Courtier, M.H., Bayle, C., Hercend, T. and Triebel, F. (1994) "T cell repertoire in patients with B chronic lymophocytic leukaemia. Evidence of multiple in vivo T cell clonal expansions", Journal of Immunology 153, 4281-4290.
78. Vuillier, F., Maloum, K., Thomas, E.K., Jouanne, C., Dighiero, G. and Scott-Algara, D. (2001) "Functional monocyte-derived dendritic cells can be generated in B-ccl", British Journal of Haematology 115, 831-844.
79. Trojan, A., Schultze, J.L., Witzens, M., Vonderheide, R.H., Ladetto, M., Donovan, J.W. and Gribben, J.G. (2000) "Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B cell malignancies", Nature Medicine 6, 667-672.
80. Porakishvili, N., Roschupkina, T., Kalber, T., Jewell, A.P., Patterson, K., Yong, K. and Lydyard, P.M. (2001) "Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL)", Clinical and Experimental Immunology 126, 29-36.